Sell Stepan for a quick gain

We are selling Stepan Company (NYSE: SCL)  from the Growth Stock Strategist portfolio. The stock is up almost 13% since our recommendation on March 3 and is just about touching our $60 target. 

The specialty chemical maker trades at 15 times 2017 estimates but is only growing at 6%. Although Stepan’s operating model is sound, the market has recognized–as we did last month–that its stock was under priced. 



Stock Talk

Add New Comments

You must be logged in to post to Stock Talk OR create an account